日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia.

CDK4/6 抑制剂可克服维奈托克耐药机制,增强其在急性髓系白血病中的联合治疗活性。

Stewart Melissa L, Gibbs Jessica, Watanabe-Smith Kevin, Nguyen Ariel, Kenna Isabel, Thiel-Klare Karina, Kaempf Andy, Bottomly Daniel, Kurtz Stephen E, Eide Christopher A, Long Nicola, Saultz Jennifer N, Sax Luca, Huang Ariane, McWeeney Shannon K, Chang Bill H, Tyner Jeffrey W

CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study

CHARM评分可预测老年人异基因移植后的发病率和毒性:BMT CTN 1704研究

Artz, Andrew S; Logan, Brent; Saber, Wael; Geller, Nancy; Bellach, Anna; Kou, Jianqun; Wood, William A; McCarty, John M; Knight, Thomas G; Runaas, Lyndsey; Johnston, Laura; Walston, Jeremy; Nakamura, Ryotaro; Mishra, Asmita; Uberti, Joseph; Dahi, Parastoo B; Saultz, Jennifer N; McCurdy, Shannon R; Morris, Lawrence; Imus, Philip; Hogan, William J; Nadiminti, Kalyan; Bhatt, Vijaya Raj; Olin, Rebecca; Maakaron, Joseph; Sobecks, Ronald; Wall, Sarah; Mattila, Deborah; Protz, Bailey; Devine, Steven M; Horowitz, Mary M; Sorror, Mohamed L

Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation

HLA-DRB1进化差异程度越高,匹配无关造血干细胞移植后复发率越低,生存率越高。

Saultz, Jennifer N; Bolon, Yung-Tsi; Wang, Tao; Spellman, Stephen R; Lee, Stephanie J; He, Meilun; Camacho-Bydume, Christine; Krishna, Chirag; Chowell, Diego; Shaffer, Brian C; Hsu, Katharine C; Paczesny, Sophie; Gadalla, Shahinaz M; Marsh, Steven G E; Betts, Brian C; Arrieta-Bolaños, Esteban

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemia

一项评估鲁索替尼联合维奈托克治疗复发/难治性急性髓系白血病患者的1期临床试验结果

Borate, Uma; Tognon, Cristina E; Madanat, Yazan F; Misra, Shikha; Kaempf, Andy; Patel, Prapti A; Davis, Kara L; Sun, Junwei; Stuani, Lucille; Eisenmann, Eric D; Eide, Christopher A; Kurtz, Stephen E; Watanabe-Smith, Kevin; Johnson, Kara; Jager, Astraea; Gullaksen, Stein-Erik; Robinson, Bridget; Vu, Tania; Plevritis, Sylvia K; Baker, Sharyn D; Minnier, Jessica; Clement, Peter; Avaylon, Sammantha; Hayes, Madison; Newell, Laura F; Gandhi, Arpita P; Leonard, Jessica; Hayes-Lattin, Brandon; Vasu, Sumithira; Cook, Rachel J; Meyers, Gabrielle; Maziarz, Richard T; Traer, Elie; Swords, Ronan; Tyner, Jeffrey W; Druker, Brian J; Saultz, Jennifer N

Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML

吉妥珠单抗奥佐米星联合阿糖胞苷、柔红霉素和米哚妥林诱导治疗FLT3突变型急性髓系白血病的安全性

Jain, Jayanshu; Pugh, Kelly; Handa, Shivani; Dvorak-Kornaus, Kaitlyn M; Zhao, Qiuhong; Walter, Roland B; Cook, Rachel; Saultz, Jennifer; Swords, Ronan; Li, Junyang; Laszlo, George S; Grieselhuber, Nicole R; Mims, Alice S; Larkin, Karilyn T M; Sahasrabudhe, Kieran; Blachly, James S; Behbehani, Gregory K; Eisfeld, Ann-Kathrin; Long, Meixiao; Srisuwananukorn, Andrew; Koenig, Kristin L; Borate, Uma

Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide vs Conventional Prophylaxis

无关供者年龄与移植后环磷酰胺预防与常规预防的受者预后

Mehta, Rohtesh S; Sparapani, Rodney A; Kanakry, Christopher G; McCurdy, Shannon R; Saultz, Jennifer; Lazaryan, Aleksandr; Milano, Filippo; Lee, Stephanie J

Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study

维奈托克治疗急性髓系白血病临床结局的遗传和表型相关性:GEN-PHEN-VEN 研究

Lachowiez, Curtis A; Heiblig, Mael; Aspas Requena, Gaspar; Tavernier-Tardy, Emmanuelle; Dai, Fangyan; Ashango, Amenech B; Peters, Daniel T; Fang, Jacob; Kaempf, Andy; Long, Nicola; Eide, Christopher A; Kurtz, Stephen E; Xie, Wei; Agarwal, Anupriya; Sahasrabudhe, Aishwarya; McMahon, Christine M; Amaya, Maria L; Meyers, Gabrielle; Gandhi, Arpita; Leonard, Jessica; Hayes-Lattin, Brandon; Maziarz, Richard T; Traer, Elie; Cook, Rachel J; Swords, Ronan; Braun, Theodore P; Saultz, Jennifer N; Eckel, Ashley M; Loken, Michael R; Zeidner, Joshua F; Tyner, Jeffrey W; Pollyea, Daniel A

Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation

供者年龄和供者巨细胞病毒血清状态对亲缘供者异基因造血干细胞移植后预后的影响

Mehta, Rohtesh S; Choe, Hannah; Saultz, Jennifer; Gong, Zimu; Sharma, Prashant; Al-Juhaishi, Taha; Petitto, Gabriela S; Lazaryan, Aleksandr; Singh, Anurag; Xue, Elisabetta; Dimitrova, Dimana; Hyder, Mustafa; McCurdy, Shannon; Im, Annie; Huber, Bryan; Aljawai, Yosra M; Kanakry, Jennifer; Milano, Filippo; Kanakry, Christopher G

Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders

MUTYH基因的种系致病变异与血液系统恶性肿瘤或疾病患者造血干细胞移植后生存率降低相关

Rafati, Maryam; Wang, Youjin; Koppayi, Ashwin L; Savage, Sharon A; Godley, Lucy A; Williams, Kirsten M; Porter, Christopher; Jones, Kristine; Hicks, Belynda; Spellman, Stephen R; He, Meilun; Atshan, Rasha; Iwuagwu, Caidon; Bolon, Yung-Tsi; Arrieta-Bolaños, Esteban; Saultz, Jennifer N; Benjamin, Cara L; Lee, Stephanie J; Saber, Wael; Gadalla, Shahinaz M

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

针对老年同种异体移植受者的新型综合健康评估风险模型:BMT-CTN 1704

Sorror, Mohamed L; Saber, Wael; Logan, Brent; Geller, Nancy; Bellach, Anna; Kou, Jianqun; Wood, William; McCarty, John M; Knight, Thomas G; Runaas, Lyndsey; Johnston, Laura; Walston, Jeremy; Nakamura, Ryotaro; Jarrett, Lori; Mishra, Asmita; Uberti, Joseph; Dahi, Parastoo B; Saultz, Jennifer N; McCurdy, Shannon R; Morris, Lawrence E; Imus, Philip H; Hogan, William J; Nadiminti, Kalyan; Bhatt, Vijaya Raj; Olin, Rebecca; Maakaron, Joseph; Sobecks, Ronald; Wall, Sarah A; Mattila, Deborah; Protz, Bailey; Devine, Steven M; Horowitz, Mary M; Artz, Andrew S